DOPATREE
Preview
Open in TheBrain
DOPATREE
DATABASE
Children
BIORESEARCH MONITORING INFORMATION SYSTEM (BMIS)
CLINICAL INVESTIGATOR INSPECTION SEARCH (CIIS, CLIIL)
EMA. EU CLINICAL TRIALS REGISTER. ACCESSED : JUN 15, 2022.
EUDRAVIGILANCE
EUROPEAN CYSTIC FIBROSIS SOCIETY (ECFS). ECFS PATIENT REGISTRY. ACCESSED : MAY 18, 2022.
EUROPEAN NETWORK OF CENTRES FOR PHARMACOEPIDEMIOLOGY AND PHARMACOVIGILANCE (ENCEPP). ENCEPP RESOURCES DATABASE. ACCESSED : MAY 18, 2022.
EUROPEAN UNION ELECTRONIC REGISTER OF POST-AUTHORISATION STUDIES (EU PAS REGISTER)
UPPSALA MONITORING CENTRE. VIGIBASE. ACCESSED : JUN 13, 2022.
US CDC-NCHS. NATIONAL VITAL STATISTICS SYSTEM (NVSS). ACCESSED : JUN 26, 2022.
US CDC-NCHS. STATE AND TERRITORIAL DATA. FASTSTATS. ACCESSED : JUN 30, 2022.
US CDC-NIOSH. DIRECTORY OF CHEMICAL SAFETY RESOURCES. ACCESSED : MAY 5, 2022.
US CDC-NIOSH. EMERGENCY RESPONSE SAFETY AND HEALTH DATABASE. ALL AGENTS: ALPHABETIZED. ACCESSED : MAY 9, 2022.
US CDC. ACTIVE BACTERIAL CORE SURVEILLANCE (ABCS). ACCESSED : APR 26, 2022.
US CDC. ADULT BLOOD LEAD EPIDEMIOLOGY AND SURVEILLANCE (ABLES). ACCESSED : APR 26, 2022.
US CDC. AIR QUALITY. ACCESSED : APR 29, 2022.
US CDC. BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM (BRFSS). ACCESSED : JUN 25, 2022.
US CDC. CHEMICAL AGENTS. EMERGENCY PREPAREDNESS AND RESPONSE. ACCESSED : APR 29, 2022.
US CDC. CURRENT VISS. ACCESSED : APR 28, 2022.
US CDC. FATALITIES IN THE OIL AND GAS EXTRACTION INDUSTRY. ACCESSED : JUN 29, 2022.
US CDC. FOODBORNE DISEASE OUTBREAK SURVEILLANCE SYSTEM (FDOSS). ACCESSED : JUL 1, 2022.
US CDC. LEARN ABOUT SPECIFIC BIRTH DEFECTS. ACCESSED : APR 18, 2022.
US CDC. NATIONAL PROGRAM OF CANCER REGISTRIES. ACCESSED : JUN 26, 2022.
US CDC. NATIONAL SYNDROMIC SURVEILLANCE PROGRAM (NSSP). ACCESSED : JUN 26, 2022.
US CDC. PARASITES A-Z INDEX. DPDX. ACCESSED : MAY 4, 2022.
US CDC. VACCINE-SPECIFIC RECOMMENDATIONS. ACCESSED : APR 28, 2022.
US CDC. VACCINES BY DISEASE. ACCESSED : APR 28, 2022.
US CODE OF FEDERAL REGULATIONS. TITLE 21. ACCESSED : MAR 23, 2022.
US FDA. 522 POSTMARKET SURVEILLANCE STUDIES DATABASE. ACCESSED : MAR 23, 2022.
US FDA. ACCELERATED APPROVALS. ACCESSED : MAR 23, 2022.
US FDA. ANIMAL DRUGS@FDA. ACCESSED : MAR 23, 2022.
US FDA. ANIMAL RULE APPROVALS. ACCESSED : MAR 23, 2022.
US FDA. APPROVED RISK EVALUATION AND MITIGATION STRATEGIES (REMS). ACCESSED : MAR 23, 2022.
US FDA. BIOLOGICAL APPROVALS BY YEAR. ACCESSED : MAR 23, 2022.
US FDA. BLOOD ESTABLISHMENT REGISTRATION. ACCESSED : MAR 23, 2022.
US FDA. BREAKTHROUGH THERAPY APPROVALS. ACCESSED : MAR 23, 2022.
US FDA. CBER ON-LINE LOGIN SCREEN. ACCESSED : MAR 23, 2022.
US FDA. CDER NEXTGEN PORTAL. ACCESSED : MAR 23, 2022.
US FDA. CDERLEARN TRAINING AND EDUCATION. ACCESSED : JUN 7, 2022.
US FDA. CDRH ADVISORY MEETING MATERIALS ARCHIVE. ACCESSED : MAR 23, 2022.
US FDA. CDRH EXPORT CERTIFICATE VALIDATION (CECV). ACCESSED : MAR 23, 2022.
US FDA. CDRH FOIA ELECTRONIC READING ROOM. ACCESSED : MAR 23, 2022.
US FDA. CFR - CODE OF FEDERAL REGULATIONS TITLE 21. (MEDICAL DEVICES ONLY) ACCESSED : JAN 3, 2022.
US FDA. CLIA - CLINICAL LABORATORY IMPROVEMENT AMENDMENTS - CURRENTLY WAIVED ANALYTES. ACCESSED : MAR 23, 2022.
US FDA. CLIA - CLINICAL LABORATORY IMPROVEMENT AMENDMENTS. ACCESSED : MAR 23, 2022.
US FDA. COMMITTEES AND MEETING MATERIALS. ACCESSED : MAR 23, 2022.
US FDA. COMPILATION OF CDER NEW MOLECULAR ENTITY (NME) DRUG AND NEW BIOLOGIC APPROVALS. ACCESSED : MAR 23, 2022.
US FDA. COMPLIANCE CHECK INSPECTIONS OF TOBACCO PRODUCT RETAILERS. ACCESSED : MAR 23, 2022.
US FDA. DEVICE CLASSIFICATION UNDER SECTION 513(F)(2)(DE NOVO). ACCESSED : MAR 23, 2022.
US FDA. DISSOLUTION METHODS. ACCESSED : MAR 23, 2022.
US FDA. DRUG ESTABLISHMENTS CURRENT REGISTRATION SITE. ACCESSED : MAR 23, 2022.
US FDA. DRUG SAFETY-RELATED LABELING CHANGES (SRLC). ACCESSED : MAR 23, 2022.
US FDA. DRUGS@FDA. ACCESSED : MAR 17, 2022.
US FDA. EFFICACY SUPPLEMENT APPROVALS. ACCESSED : MAR 23, 2022.
US FDA. ESTABLISHMENT REGISTRATION & DEVICE LISTING. ACCESSED : MAR 23, 2022.
US FDA. FAST TRACK APPROVALS. ACCESSED : MAR 23, 2022.
US FDA. FDA ACRONYMS AND ABBREVIATIONS. ACCESSED : MAR 23, 2022.
US FDA. FDA ADVERSE EVENT REPORTING SYSTEM (FAERS) PUBLIC DASHBOARD. ACCESSED : MAR 23, 2022.
US FDA. FDA DRUG SHORTAGES. ACCESSED : MAR 23, 2022.
US FDA. FDALABEL. ACCESSED : MAR 23, 2022.
US FDA. FIRST GENERIC DRUG APPROVALS. ACCESSED : MAR 23, 2022.
US FDA. FOOD DEFENSE MITIGATION STRATEGIES DATABASE (FDMSD). ACCESSED : MAR 23, 2022.
US FDA. GRAS NOTICES. MAR 23, 2022.
US FDA. GUIDANCE. 510(K) PREMARKET NOTIFICATION. ACCESSED : MAR 23, 2022.
US FDA. HUMAN CELL AND TISSUE ESTABLISHMENT REGISTRATION (HCTERS). ACCESSED : MAR 23, 2022.
US FDA. HUMANITARIAN DEVICE EXEMPTION (HDE). ACCESSED : MAR 23, 2022.
US FDA. INACTIVE INGREDIENT SEARCH FOR APPROVED DRUG PRODUCTS. ACCESSED : MAR 23, 2022.
US FDA. INSPECTIONS. ACCESSED : MAR 23, 2022.
US FDA. INVENTORY OF FOOD CONTACT SUBSTANCES LISTED IN 21 CFR. ACCESSED : MAR 23, 2022.
US FDA. MAMMOGRAPHY FACILITIES. ACCESSED : MAR 23, 2022.
US FDA. MAUDE - MANUFACTURER AND USER FACILITY DEVICE EXPERIENCE (GENERAL SEARCH). ACCESSED : MAR 23, 2022.
US FDA. MAUDE - MANUFACTURER AND USER FACILITY DEVICE EXPERIENCE. MAR 23, 2022.
US FDA. MDR DATABASE SEARCH. ACCESSED : MAR 23, 2022.
US FDA. MEDICAL DEVICE RECALLS. ACCESSED : MAR 23, 2022.
US FDA. MEDICATION GUIDES. ACCESSED : MAR 23, 2022.
US FDA. MEDSUN REPORTS. ACCESSED : MAR 23, 2022.
US FDA. NATIONAL DRUG CODE DIRECTORY. ACCESSED : MAR 23, 2022.
US FDA. NDA AND BLA CALENDAR YEAR APPROVALS. ACCESSED : MAR 23, 2022.
US FDA. NEW DRUGS AT FDA : CDER’S NEW MOLECULAR ENTITIES AND NEW THERAPEUTIC BIOLOGICAL PRODUCTS. ACCESSED : MAR 17, 2022.
US FDA. NOVEL DRUG APPROVALS
US FDA. OPEN FDA. ANIMAL & VETERINARY ADVERSE EVENTS OVERVIEW. ACCESSED : MAR 23, 2022.
US FDA. OPENFDA. ACCESSED : MAR 23, 2022.
US FDA. ORANGE BOOK. ACCESSED : MAR 17, 2022.
US FDA. OTC - OVER THE COUNTER. ACCESSED : MAR 23, 2022.
US FDA. OTC MONOGRAPHS@FDA. ACCESSED : MAR 23, 2022.
US FDA. OUTSOURCING FACILITY PRODUCT REPORT. ACCESSED : MAR 23, 2022.
US FDA. POST-APPROVAL STUDIES (PAS) DATABASE. ACCESSED : MAR 23, 2022.
US FDA. POSTMARKET REQUIREMENTS AND COMMITMENTS. ACCESSED : MAR 23, 2022.
US FDA. PREMARKET APPROVAL (PMA) SUMMARY REVIEW MEMOS FOR 180-DAY DESIGN CHANGES. ACCESSED : MAR 23, 2022.
US FDA. PREMARKET APPROVAL (PMA). ACCESSED : MAR 23. 2022.
US FDA. PRESIDENT’S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR) DATABASE. ACCESSED : MAR 23, 2022.
US FDA. PRIORITY NDA AND BLA APPROVALS. ACCESSED : MAR 23, 2022.
US FDA. PRODUCT CLASSIFICATION. ACCESSED : MAR 23, 2022.
US FDA. PRODUCT-SPECIFIC GUIDANCES FOR GENERIC DRUG DEVELOPMENT. ACCESSED : MAR 23, 2022.
US FDA. PURPLE BOOK. ACCESSED : MAR 17, 2022.
US FDA. RADIATION EMITTING ELECTRONIC PRODUCT CODES. ACCESSED : MAR 23, 2022.
US FDA. RADIATION-EMITTING ELECTRONIC PRODUCTS CORRECTIVE ACTIONS. ACCESSED : MAR 23, 2022.
US FDA. RECOGNIZED CONSENSUS STANDARDS. ACCESSED : MAR 23, 2022.
US FDA. REGISTERED OUTSOURCING FACILITIES. ACCESSED : MAR 23, 2022.
US FDA. SEARCH FOOD INGREDIENT AND PACKAGING INVENTORIES. ACCESSED : MAR 23, 2022.
US FDA. SEARCH FOR FDA GUIDANCE DOCUMENTS. ACCESSED : MAR 23, 2022.
US FDA. SEARCH ORPHAN DRUG DESIGNATIONS AND APPROVALS. ACCESSED : MAR 23, 2022.
US FDA. SUBSTANCES ADDED TO FOOD (FORMERLY EAFUS)
US FDA. TOBACCO ESTABLISHMENT REGISTRATION & TOBACCO PRODUCT LISTING. ACCESSED : MAR 23, 2022.
US FDA. TPLC - TOTAL PRODUCT LIFE CYCLE. ACCESSED : MAR 23 2022.
US FDA. WARNING LETTERS. ACCESSED : MAR 23, 2022.
US FDA. WHOLESALE DISTRIBUTOR AND THIRD-PARTY LOGISTICS PROVIDERS REPORTING. ACCESSED : MAR 23, 2022.
US FDA. X-RAY ASSEMBLER. MAR 23, 2022.
US NIH-GARD. LIST OF FDA ORPHAN DRUGS. ACCESSED : MAR 23, 2022.
US NIH-NATIONAL LIBRARY OF MEDICINE. ACCESS GLOBAL UNIQUE DEVICE IDENTIFICATION DATABASE (GUDID). ACCESSED : MAR 23, 2022.
US NIH-NATIONAL LIBRARY OF MEDICINE. DAILYMED. ACCESSED : MAR 23, 2022.
US NIH-NCI. A TO Z LIST OF CANCER DRUGS. ACCESSED : MAR 23, 2022.
US NIH-NCI. LIST OF CANCER TYPES. ACCESSED : APR 18, 2022.
US NIH-NCI. PDQ® CANCER INFORMATION SUMMARIES. ACCESSED: APR 18, 2022.
US NIH-NEI. EYE CONDITIONS AND DISEASES. ACCESSED : APR 18, 2022.
US NIH-NHLBI. HEALTH TOPICS. ACCESSED : APR 18, 2022.
US NIH-NIAMS. ALL DISEASES AND CONDITIONS. ACCESSED : APR 19, 2022.
US NIH-NICHD. A TO Z TOPICS INDEX. ACCESSED : APR 18, 2022.
US NIH-NLM. BROWSE DRUG CLASSES. DAILYMED. ACCESSED : MAY 10, 2022.
US NIH-NLM. CLINICALTRIALS.GOV. ACCESSED : JUN 15, 2022.
WASHINGTION UNIVERSITY IN ST. LOUIS. CLINICAL DRUG EXPERIENCE KNOWLEDGEBASE (CDEK). ACCESSED : MAR 23, 2022.
WHO. INTERNATIONAL CLINICAL TRIALS REGISTRY PLATFORM. ACCESSED : JUN 15, 2022.
WHO. VIGIACCESS. ACCESSED : JUN 13, 2022.